Clinical Medicine

Clinical Medicine, Biomarkers, and Therapy

Surveys current clinical-medicine topics including stem-cell therapy, clinical trials, and biomarkers.

• What Happened When Stem Cells Were Infused for Acute Ischaemic Stroke — MASTERS and the Answer 'No Difference'
• Leaving Stem Cells Behind in the Chronic Stroke Brain — SB623, Two-Year Results in 18 Patients, and the Reckoning That Came Afterward
• “The Primary Efficacy Endpoint Was Not Met” — What PISCES-2, Which Implanted Neural Stem Cells into the Brain, Really Left Behind
• Antibody ALMB-0166 Calms Overactive Astrocytes — Safety and Early Signals from a First-in-Human Trial in Spinal Cord Injury
• Knee Joint Injections: Which One Actually Works?—From Steroids to Exosomes, Decoding 9 Treatments at the Molecular Level
• “Can Stem Cells Cure ALS?” — What a Phase 3 Trial That Missed Its Primary Endpoint Still Taught Us
• Move Your Own Hand by Thought Alone, and Feel It Touch: A 'Double Neural Bypass' Takes On Complete Spinal Cord Injury
• Rewiring the Link Between "Muscle" and "Brain"—Cognitive-Motor Integration (CMI), the Key to Reclaiming Cognition Through Exercise in Neurological Disease
• Stem Cell Clinical Science: Introduction.
• An Overview of Stem Cell Therapy in Japan: Current Status, Risks, and Future Prospects
• A new treatment for hemophilia: from the Lancet
• What Is ATTR Cardiac Amyloidosis? A Thorough Explanation of the Efficacy and Safety of the Latest Treatment, Patisiran — From the Results of the NEJM APOLLO-B Trial
• TAVR (Transcatheter Aortic Valve Replacement): An Innovative Advance in Heart Disease Treatment
• Blood Biomarkers of Multimorbidity: Probing the Mechanisms of Aging Through Shared and Specific Features